Grant: Operating Grant
McGill University
$597,720.00
Dissecting the mechanisms required to regulate metabolism and tumour growth downstream of LKB1/AMPK signalling.
EF 2009-10
Résumé
Peutz-Jeghers Syndrome (PJS) is a genetic disease that makes patients succeptible to tumour growth and cancer. These patients have a 500-fold increased risk of developing cancer in the small intestine, and also in other tissues/organs. The mutation that causes this predisposition occurs in a protein kinase-a gene product that makes an enzyme which activates and inactivates numerous other proteins. This protein, called LKB1, is particularly curious because it plays multiple, seemingly unrelated roles in the cell. We do not understand how LKB1 carries out these essential tasks, nor which ones are absolutely required to block the formation of tumours but we intend to use a simple model and modern genetic and molecular approaches to resolve this problem with the hope of finding ways to better harness this activity and block tumour growth.
Programme
Operating Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
200008
Name
Roy Richard D
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Molecular & Cellular Biology of Cancer
Projecttitle
Dissecting the mechanisms required to regulate metabolism and tumour growth downstream of LKB1/AMPK signalling.
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$597,720
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Ampk; Autophagy; C. Elegans; Cell Polarity; Dauer; Lipid Hydrolysis/Metabolism; Lkb1; Peutz Jeghers Syndrome; Rnai; Tumour Suppressor
Abstract
Peutz-Jeghers Syndrome (PJS) is a genetic disease that makes patients succeptible to tumour growth and cancer. These patients have a 500-fold increased risk of developing cancer in the small intestine, and also in other tissues/organs. The mutation that causes this predisposition occurs in a protein kinase-a gene product that makes an enzyme which activates and inactivates numerous other proteins. This protein, called LKB1, is particularly curious because it plays multiple, seemingly unrelated roles in the cell. We do not understand how LKB1 carries out these essential tasks, nor which ones are absolutely required to block the formation of tumours but we intend to use a simple model and modern genetic and molecular approaches to resolve this problem with the hope of finding ways to better harness this activity and block tumour growth.
Competitiondate
201003
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Roy, Richard D
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $597,720~ $0~